PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 600.0
(-0.83%)
IDR 600.0
(-0.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4350.51 Billion IDR | 34.9% |
| 2022 | 3240.75 Billion IDR | -6.65% |
| 2021 | 3471.7 Billion IDR | 9.72% |
| 2020 | 3164.02 Billion IDR | -1.49% |
| 2019 | 3211.85 Billion IDR | 47.06% |
| 2018 | 2183.97 Billion IDR | 22.85% |
| 2017 | 1777.8 Billion IDR | 21.78% |
| 2016 | 1459.85 Billion IDR | 19.7% |
| 2015 | 1219.6 Billion IDR | 10.89% |
| 2014 | 1099.83 Billion IDR | 5.49% |
| 2013 | 1042.61 Billion IDR | 14.25% |
| 2012 | 912.59 Billion IDR | 11.84% |
| 2011 | 816.01 Billion IDR | 7.61% |
| 2010 | 758.32 Billion IDR | 12.13% |
| 2009 | 676.31 Billion IDR | 9.93% |
| 2008 | 615.21 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 855.39 Billion IDR | -54.58% |
| 2024 Q3 | 794.38 Billion IDR | -10.75% |
| 2024 Q2 | 890.06 Billion IDR | 4.05% |
| 2023 Q4 | 1883.13 Billion IDR | 80.08% |
| 2023 Q1 | 830.19 Billion IDR | 17.85% |
| 2023 FY | 4371.74 Billion IDR | 34.9% |
| 2023 Q2 | 895.39 Billion IDR | 7.85% |
| 2023 Q3 | 1045.72 Billion IDR | 16.79% |
| 2022 Q3 | 941.38 Billion IDR | 7.31% |
| 2022 FY | 3240.75 Billion IDR | -6.65% |
| 2022 Q4 | 704.43 Billion IDR | -25.17% |
| 2022 Q2 | 877.25 Billion IDR | 22.23% |
| 2022 Q1 | 717.68 Billion IDR | -22.36% |
| 2021 Q1 | 708.81 Billion IDR | -23.36% |
| 2021 Q4 | 924.41 Billion IDR | -8.91% |
| 2021 FY | 3471.7 Billion IDR | 9.72% |
| 2021 Q3 | 1014.86 Billion IDR | 23.22% |
| 2021 Q2 | 823.61 Billion IDR | 16.2% |
| 2020 Q1 | 720.76 Billion IDR | -27.61% |
| 2020 FY | 3164.02 Billion IDR | -1.49% |
| 2020 Q2 | 794.08 Billion IDR | 10.17% |
| 2020 Q3 | 724.33 Billion IDR | -8.78% |
| 2020 Q4 | 924.85 Billion IDR | 27.68% |
| 2019 Q4 | 995.64 Billion IDR | 29.31% |
| 2019 Q1 | 578.88 Billion IDR | -7.16% |
| 2019 Q2 | 867.35 Billion IDR | 49.83% |
| 2019 Q3 | 769.96 Billion IDR | -11.23% |
| 2019 FY | 3211.85 Billion IDR | 47.06% |
| 2018 Q4 | 623.51 Billion IDR | 15.53% |
| 2018 Q2 | 590.18 Billion IDR | 37.07% |
| 2018 Q1 | 430.57 Billion IDR | -18.16% |
| 2018 FY | 2183.97 Billion IDR | 22.85% |
| 2018 Q3 | 539.7 Billion IDR | -8.55% |
| 2017 Q3 | 436.15 Billion IDR | -11.82% |
| 2017 Q4 | 526.12 Billion IDR | 20.63% |
| 2017 Q2 | 494.59 Billion IDR | 54.11% |
| 2017 Q1 | 320.92 Billion IDR | -27.68% |
| 2017 FY | 1777.8 Billion IDR | 21.78% |
| 2016 Q2 | 363.43 Billion IDR | 22.35% |
| 2016 FY | 1459.85 Billion IDR | 19.7% |
| 2016 Q4 | 443.77 Billion IDR | 24.8% |
| 2016 Q1 | 297.05 Billion IDR | -17.15% |
| 2016 Q3 | 355.59 Billion IDR | -2.15% |
| 2015 Q3 | 311.82 Billion IDR | 7.54% |
| 2015 FY | 1219.6 Billion IDR | 10.89% |
| 2015 Q1 | 259.3 Billion IDR | -23.62% |
| 2015 Q2 | 289.95 Billion IDR | 11.82% |
| 2015 Q4 | 358.52 Billion IDR | 14.98% |
| 2014 Q4 | 339.46 Billion IDR | 22.64% |
| 2014 FY | 1099.83 Billion IDR | 5.49% |
| 2014 Q1 | 231.62 Billion IDR | -29.91% |
| 2014 Q3 | 276.8 Billion IDR | 9.87% |
| 2014 Q2 | 251.93 Billion IDR | 8.77% |
| 2013 Q1 | 206.87 Billion IDR | -27.77% |
| 2013 Q3 | 260.15 Billion IDR | 6.12% |
| 2013 Q4 | 330.45 Billion IDR | 27.02% |
| 2013 FY | 1042.61 Billion IDR | 14.25% |
| 2013 Q2 | 245.14 Billion IDR | 18.5% |
| 2012 Q3 | 239.77 Billion IDR | 12.15% |
| 2012 Q4 | 286.4 Billion IDR | 19.44% |
| 2012 Q1 | 172.6 Billion IDR | -33.97% |
| 2012 Q2 | 213.8 Billion IDR | 23.87% |
| 2012 FY | 912.59 Billion IDR | 11.84% |
| 2011 Q2 | 191.79 Billion IDR | 19.44% |
| 2011 Q3 | 202.2 Billion IDR | 5.42% |
| 2011 Q4 | 261.42 Billion IDR | 29.29% |
| 2011 FY | 816.01 Billion IDR | 7.61% |
| 2011 Q1 | 160.58 Billion IDR | 0.0% |
| 2010 FY | 758.32 Billion IDR | 12.13% |
| 2009 FY | 676.31 Billion IDR | 9.93% |
| 2008 FY | 615.21 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 1992.05 Billion IDR | -118.394% |
| PT Itama Ranoraya Tbk | 100.18 Billion IDR | -4242.427% |
| PT Millennium Pharmacon International Tbk | 184.42 Billion IDR | -2259.008% |
| PT Soho Global Health Tbk | 851.38 Billion IDR | -410.993% |